SAB Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $81.1M
Liabilities Breakdown FY2021
Total Liabilities: $42.6M
Asset Breakdown
Total Assets: $81.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $33.2M | 40.9% |
| Accounts Receivable | $8.0M | 9.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $24.3M | 30.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $15.6M | 19.2% |
Liabilities Breakdown
Total Liabilities: $42.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.5M | 10.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $38.1M | 89.5% |